Briacell Therapeutics Corp BCTX

$3.43 +0.02 (0.73%)

Valuation

Market cap
29,884,000
Revenue TTM
$0
Net income TTM
$-26,310,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
65,800
Avg volume
311,856
Day's range
$3.32 – $3.64
Shares out
8,700,000
Stochastic %K
20%
Beta
1.21
Analysts
Strong Buy
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

valueinvestor1998 Oct 24, 5:41 PM
$BCTX does someone have access to the transcript of the last interview of the CEO?
1 replies
JediGreen Oct 24, 5:14 AM
$BCTX I got to say after watching Moderna’s stock gain like 90 billion and tanked on there results. I got to say I might be under estimating what a buy out price could be if BriaCells phase 3 is good and this technology shows promising results. Just look at there pipeline what they are working on. My prediction is their company could be valued at 30 to 50 billion price tag for a buy out if phase 3 is good.
1 replies
JediGreen Oct 24, 4:46 AM
$BCTX I got to say what did Moderna’s stock gain on there melanoma phase 3 like 90 billion. I literally look at the market and think what are you guys thinking. I see this technology being better than what they are working on in my opinion. They got the big recognizable name is what it is. But this is a diamond in the dirt waiting to be recognized. Market is blind at times. 
0 replies
JediGreen Oct 24, 3:48 AM
$BCTX https://youtu.be/5degIsw-fTI
0 replies
Rohtan Oct 24, 1:40 AM
$BCTX looking for 1s.
0 replies
MoeMaze Oct 23, 11:18 PM
$BCTX BCTX’s next catalyst? 🚨 A new public offering coming soon… probably. Because no BCTX rally is complete without management turning it into a fundraising event. Buy the rumor, dilute the rally.
2 replies
SmallCapGrowth Oct 23, 6:35 PM
🚀 $BCTX continues advancing its immunotherapy research. New ESMO 2026 biomarker findings highlight a potential avenue for understanding clinical outcomes in metastatic breast cancer. https://www.globenewswire.com/news-release/2026/10/23/3387183/0/en/briacell-announces-esmo-2026-poster-highlighting-circulating-immune-biomarker-associated-with-clinical-outcomes-in-metastatic-breast-cancer.html #BriaCell #BCTX
0 replies
SmallCapGrowth Oct 23, 5:24 PM
$BCTX at ESMO 2026! A pooled - Xtremepicks Alerts https://investorshangout.com/post/view?id=6849723
0 replies